argenx Balance Sheet Health
Financial Health criteria checks 4/6
argenx has a total shareholder equity of $4.3B and total debt of $34.0M, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are $4.8B and $534.3M respectively.
Key information
0.8%
Debt to equity ratio
US$33.96m
Debt
Interest coverage ratio | n/a |
Cash | US$3.10b |
Equity | US$4.26b |
Total liabilities | US$534.31m |
Total assets | US$4.80b |
Recent financial health updates
No updates
Recent updates
Are Investors Undervaluing argenx SE (EBR:ARGX) By 34%?
Dec 21Investor Optimism Abounds argenx SE (EBR:ARGX) But Growth Is Lacking
Nov 03Is argenx SE (EBR:ARGX) Trading At A 45% Discount?
Aug 24Results: argenx SE Confounded Analyst Expectations With A Surprise Profit
Jul 29argenx SE's (EBR:ARGX) Shares Climb 26% But Its Business Is Yet to Catch Up
Jun 26argenx SE's (EBR:ARGX) CEO Looks Like They Deserve Their Pay Packet
May 01Investors Appear Satisfied With argenx SE's (EBR:ARGX) Prospects
Apr 11Analyst Estimates: Here's What Brokers Think Of argenx SE (EBR:ARGX) After Its Yearly Report
Mar 24Analysts Have Made A Financial Statement On argenx SE's (EBR:ARGX) Full-Year Report
Mar 05argenx SE (EBR:ARGX) Shares Could Be 24% Below Their Intrinsic Value Estimate
Feb 23Financial Position Analysis
Short Term Liabilities: ARGX's short term assets ($4.3B) exceed its short term liabilities ($499.6M).
Long Term Liabilities: ARGX's short term assets ($4.3B) exceed its long term liabilities ($34.7M).
Debt to Equity History and Analysis
Debt Level: ARGX has more cash than its total debt.
Reducing Debt: ARGX's debt to equity ratio has increased from 0.7% to 0.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ARGX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ARGX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 00:45 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
argenx SE is covered by 49 analysts. 28 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Joel Beatty | Baird |
Charles Pitman-King | Barclays |
Richard Parkes | BNP Paribas Exane |